Company / Financials
BIODESIX INC Financials
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$88.5M
FY2025 · +24.1% YoY
Net Income
-$35.3M
FY2025 · +17.9% YoY
Profit Margin
-39.9%
FY2025 · net income / revenue
ROE
-
FY2025 · return on equity
Total Assets
$87.5M
FY2025
Total Debt
$50.0M
-20.29x debt/equity
Equity
-$2.5M
FY2025
ROA
-40.3%
FY2025 · return on assets
Statement paths
Metric history
Revenue HistoryTotal revenue from operations$88.5M+24.1% YoYNet Income HistoryProfit after all expenses and taxes-$35.3M+17.9% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$27.9M+19.2% YoYSG&A Expense HistorySelling, general, and administrative expenses$87.5M+8.8% YoYR&D Expense HistoryResearch and development spending$12.0M+25.5% YoYInterest Expense HistoryCost of borrowing and debt obligations$7.7M-6.6% YoYIncome Tax HistoryTotal income tax expense$0EPS (Basic) HistoryBasic earnings per share-$6.64-937.5% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$6.64-937.5% YoYShares Outstanding HistoryWeighted average diluted shares outstanding7.3M-92.4% YoY